EXPERIENCE OF THE USE OF DEFERASIROX IN PAEDIATRIC PATIENTS WITH TRANSFUSIONAL DEPENDENCY

被引：0
|
作者：
Faci Cristina, Martinez [1 ]
Sanjuan Laura, Murillo [1 ]
Cebrian Flor, Yus [2 ]
Maria Angeles, Montanes Gracia [2 ]
Flores Maria Del Valle, Recasens [2 ]
Iturrate Carmen, Rodriguez-Vigil [1 ]
机构：
[1] Hosp Univ Miguel Servet, Serv Pediat, Zaragoza, Spain
[2] Hosp Univ Miguel Servet, Serv Hematol, Zaragoza, Spain
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PC-320
引用
收藏
页码：265 / 265
页数：1
相关论文
共 50 条
  • [21] LONG-TERM IRON CHELATION THERAPY WITH DEFERASIROX IN PEDIATRIC PATIENTS WITH TRANSFUSIONAL HEMOSIDEROSIS (ENTRUST)
    Vichinsky, Elliott
    El-Beshlawy, Amal
    Alzoebie, Azzam
    Kamdem, Annie
    Koussa, Suzanne
    Chotsampancharoen, Thirachit
    Bruederle, Andreas
    Han, Jackie
    Elalfy, Mohsen
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (08) : E444 - E444
  • [22] International sentinel site surveillance of patients with transfusional hemosiderosis treated with deferasirox in actual practice setting
    Ei-Beshlawy, Amal
    Inusa, Baba
    Beneitez Pastor, David
    Xicoy, Blanca
    Duran Nieto, Maria Soledada
    Bruederle, Andreas
    Azmon, Amin
    Gilotti, Geralyn
    Elalfy, Mohsen
    HEMATOLOGY, 2019, 24 (01) : 238 - 246
  • [23] Deferasirox pharmacokinetic evaluation in b-thalassaemia paediatric patients
    Allegra, Sarah
    Cusato, Jessica
    De Francia, Silvia
    Pirro, Elisa
    Massano, Davide
    Piga, Antonio
    D'Avolio, Antonio
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2017, 69 (05) : 525 - 528
  • [24] Deferasirox for managing transfusional iron overload in people with sickle cell disease
    Meerpohl, Joerg J.
    Antes, Gerd
    Ruecker, Gerta
    Fleeman, Nigel
    Niemeyer, Charlotte
    Bassler, Dirk
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (08):
  • [25] EFFICACY, EFFICIENCY AND SAFETY OF DEFERASIROX FOR TREATING TRANSFUSIONAL IRON OVERLOAD IN NON-ACTIVELY TRANSFUSED PATIENTS
    Kattamis, A.
    Lazopoulou, N.
    Rigatou, E.
    Kostaridou, S.
    Lourida, A.
    Ladis, V.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 513 - 513
  • [26] Deferasirox for managing transfusional iron overload in people with sickle cell disease
    Meerpohl, Joerg J.
    Schell, Lisa K.
    Ruecker, Gerta
    Motschall, Edith
    Fleeman, Nigel
    Niemeyer, Charlotte M.
    Bassler, Dirk
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (05): : 1 - 77
  • [27] Use of prior knowledge and extrapolation in paediatric drug development: A case study with deferasirox
    Borella, Elisa
    Oosterholt, Sean
    Magni, Paolo
    Della Pasqua, Oscar
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 136
  • [28] Navigating the unknown: paediatric deferasirox overdose
    Jagarlamudi, Bash
    Chiew, Angela
    Chan, Betty
    TOXICOLOGY COMMUNICATIONS, 2024, 8 (01)
  • [29] IRON CHELATION THERAPY WITH DEFERASIROX FOR TRANSFUSIONAL IRON-OVERLOADED PATIENTS WITH APLASTIC ANAEMIA AND OTHER RARE ANAEMIAS
    Porter, J. B.
    Yoon, S. -S.
    Shen, Z. X.
    Thein, S. L.
    Lin, K. -H.
    Habr, D.
    Domokos, G.
    Roubert, B.
    Lee, J. W.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 80 - 80
  • [30] Deferasirox: experience in time
    Perrotta, S.
    Casale, M.
    HEMATOLOGY REPORTS, 2010, 2 (01)
12345